Use of FAM135B inhibitor in treatment and/or prevention of esophageal squamous cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI
- Publication Date
- 2015-09-02
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the technical field of FAM135B inhibitor in the treatment and / or prevention of esophageal squamous cell carcinoma. On the other hand, the present invention relates to the technical field of FAM135B gene mutation in the diagnosis and / or prognosis of esophageal squamous cell carcinoma. Background technique
[0002] Esophageal cancer is a common digestive tract tumor. About 300,000 people die from esophageal cancer every year in the world, and it is the sixth leading cause of cancer death in the world. See Kamangar, F., G.M.Dores, et al. (2006). "Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world." J Clin Oncol 24(14):2137-2150. About 70% of esophageal cancer in the world occurs in China, and 90% of esophageal cancer in China is esophageal squamous cell carcinoma. So far, little is known about the me...